Pliant Therapeutics (PLRX)

• Market cap: $103M
• 1 day: 2.44%
• 5 days: -7.18%
• 1 month: 13.51%
• 3 months: 15.07%
• 6 months: 5.66%
• Year to date: -87.35%
• 1 year: -88.06%
• 5 years: -92.06%
• 10 years: -92.11%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Employees: 171